2406

    524558

    NEULANDLAB

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    NEULAND LAB LTD. Share Price Today

    NEULAND LAB LTD. is currently trading at ₹19200, down by ₹497.0 from the previous close. The stock touched an intraday high of ₹19676.00 and a low of ₹18951.00 during the latest trading session. Over the past one year, NEULAND LAB LTD. has delivered a return of 42.31%, while the stock has gained 8.89% in the last one month.

    NEULAND LAB LTD. performance

    Today’s low Today’s high
    ₹ 18951.00 ₹ 19676.00
    ₹ 19202.00
    52 week low 52 week high
    ₹ 11500.00 ₹ 20089.00
    ₹ 19202.00
    Open Price ₹ 19676.00
    Prev. Close ₹ 19697.00
    Volume (Shares) 55859.00
    Total traded value ₹ 10726.04
    Upper Circuit ₹ 23636.00
    Lower Circuit ₹ 15758.00
    info

    Investment Returns

    Over 1 Month 8.89% Over 3 Months 34.39% Over 6 Months 56.88% Over 1 Year 42.31%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    NEULAND LAB LTD. fundamentals


    • Market cap (Cr) 24,636.00
    • P/E Ratio (TTM) 69.67
    • Beta 0.89
    • Book Value / share 1,453.59
    • Return on equity 21.47%
    • EPS (TTM) 280.77
    • Dividend yield 0.17%
    • Net profit/quarter (Cr) 212.52
    info icon alternate text
    • Market cap (Cr) 24,655.20
    • P/E Ratio (TTM) 69.67
    • Beta 0.84
    • Book Value / share 1,453.59
    • Return on equity 21.47%
    • EPS (TTM) 280.77
    • Dividend yield 0.17%
    • Net profit/quarter (Cr) 212.52
    info icon alternate text

    NEULAND LAB LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 776.25
    Operating Expense 501.66
    Net Profit 212.52
    Net Profit Margin (%) 27.37
    Earnings Per Share (EPS) 165.65
    EBITDA 319.36
    Effective Tax Rate (%) 25.96
    Particulars DEC 2025 (Values in Cr)
    Revenue 439.71
    Operating Expense 393.49
    Net Profit 40.42
    Net Profit Margin (%) 9.19
    Earnings Per Share (EPS) 31.50
    EBITDA 84.98
    Effective Tax Rate (%) 25.53
    Particulars SEP 2025 (Values in Cr)
    Revenue 514.27
    Operating Expense 387.03
    Net Profit 96.46
    Net Profit Margin (%) 18.75
    Earnings Per Share (EPS) 75.18
    EBITDA 156.92
    Effective Tax Rate (%) 25.24
    Particulars JUN 2025 (Values in Cr)
    Revenue 292.75
    Operating Expense 283.22
    Net Profit 13.71
    Net Profit Margin (%) 4.68
    Earnings Per Share (EPS) 10.68
    EBITDA 42.15
    Effective Tax Rate (%) 21.11
    Particulars MAR 2025 (Values in Cr)
    Revenue 328.36
    Operating Expense 296.85
    Net Profit 27.73
    Net Profit Margin (%) 8.44
    Earnings Per Share (EPS) 21.62
    EBITDA 58.22
    Effective Tax Rate (%) 28.86
    Particulars MAR 2026 (Values in Cr)
    Revenue 2022.99
    Operating Expense 1565.42
    Net Profit 363.11
    Net Profit Margin (%) 17.94
    Earnings Per Share (EPS) 283.01
    EBITDA 603.41
    Effective Tax Rate (%) 25.55
    Particulars MAR 2025 (Values in Cr)
    Revenue 1476.84
    Operating Expense 1228.37
    Net Profit 259.43
    Net Profit Margin (%) 17.56
    Earnings Per Share (EPS) 202.20
    EBITDA 419.21
    Effective Tax Rate (%) 24.88
    Particulars MAR 2024 (Values in Cr)
    Revenue 1558.58
    Operating Expense 1170.36
    Net Profit 299.60
    Net Profit Margin (%) 19.22
    Earnings Per Share (EPS) 233.51
    EBITDA 474.46
    Effective Tax Rate (%) 25.24
    Particulars MAR 2023 (Values in Cr)
    Revenue 1191.20
    Operating Expense 985.74
    Net Profit 163.12
    Net Profit Margin (%) 13.69
    Earnings Per Share (EPS) 127.14
    EBITDA 281.06
    Effective Tax Rate (%) 24.20
    Particulars MAR 2022 (Values in Cr)
    Revenue 951.08
    Operating Expense 871.41
    Net Profit 63.53
    Net Profit Margin (%) 6.67
    Earnings Per Share (EPS) 49.74
    EBITDA 144.26
    Effective Tax Rate (%) 22.27
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 1452.37
    ROE % 21.43
    ROCE % 26.45
    Total Debt to Total Equity 0.13
    EBITDA Margin 29.89
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 1181.32
    ROE % 12.39
    ROCE % 18.58
    Total Debt to Total Equity 0.09
    EBITDA Margin 23.77
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 993.66
    ROE % 26.38
    ROCE % 33.01
    Total Debt to Total Equity 0.10
    EBITDA Margin 30.49
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 769.94
    ROE % 17.84
    ROCE % 20.58
    Total Debt to Total Equity 0.20
    EBITDA Margin 23.64
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 650.88
    ROE % 7.85
    ROCE % 9.23
    Total Debt to Total Equity 0.26
    EBITDA Margin 15.21
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 1445.69
    ROE % 21.47
    ROCE % 26.50
    Total Debt to Total Equity 0.14
    EBITDA Margin 29.83
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 1175.89
    ROE % 12.40
    ROCE % 18.61
    Total Debt to Total Equity 0.09
    EBITDA Margin 23.71
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 988.88
    ROE % 26.48
    ROCE % 33.13
    Total Debt to Total Equity 0.10
    EBITDA Margin 30.44
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 765.49
    ROE % 17.90
    ROCE % 20.64
    Total Debt to Total Equity 0.20
    EBITDA Margin 23.59
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 647.06
    ROE % 7.86
    ROCE % 9.24
    Total Debt to Total Equity 0.26
    EBITDA Margin 15.17
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 354.96
    Total Assets 2930.13
    Total Liabilities 2930.13
    Total Equity 1874.47
    Share Outstanding 1
    Price to Book Ratio 8.31
    Return on Assets (%) 12.42
    Return on Capital (%) 17.58
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 258.81
    Total Assets 2179.88
    Total Liabilities 2179.88
    Total Equity 1524.80
    Share Outstanding 1
    Price to Book Ratio 10.27
    Return on Assets (%) 11.93
    Return on Capital (%) 15.66
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 116.79
    Total Assets 1832.56
    Total Liabilities 1832.56
    Total Equity 1282.70
    Share Outstanding 1
    Price to Book Ratio 6.35
    Return on Assets (%) 16.37
    Return on Capital (%) 21.98
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 59.10
    Total Assets 1579.76
    Total Liabilities 1579.76
    Total Equity 994.09
    Share Outstanding 1
    Price to Book Ratio 2.35
    Return on Assets (%) 10.35
    Return on Capital (%) 14.66
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 20.35
    Total Assets 1383.48
    Total Liabilities 1383.48
    Total Equity 840.50
    Share Outstanding 1
    Price to Book Ratio 1.59
    Return on Assets (%) 4.61
    Return on Capital (%) 5.96
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 353.60
    Total Assets 2928.33
    Total Liabilities 2928.33
    Total Equity 1865.85
    Share Outstanding 1
    Price to Book Ratio 8.31
    Return on Assets (%) 12.39
    Return on Capital (%) 17.61
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 257.26
    Total Assets 2178.17
    Total Liabilities 2178.17
    Total Equity 1517.79
    Share Outstanding 1
    Price to Book Ratio 10.27
    Return on Assets (%) 11.91
    Return on Capital (%) 15.69
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 115.28
    Total Assets 1830.92
    Total Liabilities 1830.92
    Total Equity 1276.53
    Share Outstanding 1
    Price to Book Ratio 6.35
    Return on Assets (%) 16.36
    Return on Capital (%) 22.04
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 58.64
    Total Assets 1579.33
    Total Liabilities 1579.33
    Total Equity 988.36
    Share Outstanding 1
    Price to Book Ratio 2.35
    Return on Assets (%) 10.32
    Return on Capital (%) 14.7
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 18.98
    Total Assets 1382.12
    Total Liabilities 1382.12
    Total Equity 835.57
    Share Outstanding 1
    Price to Book Ratio 1.59
    Return on Assets (%) 4.59
    Return on Capital (%) 5.96
    Particulars MAR 2026 (Values in Cr)
    Net Income 488.97
    Cash from Operations 450.20
    Cash from Investing -423.73
    Cash from Financing 20.97
    Net change in Cash -56.07
    Free Cash Flow 847.34
    Particulars MAR 2025 (Values in Cr)
    Net Income 346.32
    Cash from Operations 392.13
    Cash from Investing -298.15
    Cash from Financing 24.96
    Net change in Cash 44.20
    Free Cash Flow 598.59
    Particulars MAR 2024 (Values in Cr)
    Net Income 401.43
    Cash from Operations 372.78
    Cash from Investing -149.68
    Cash from Financing -69.28
    Net change in Cash 42.20
    Free Cash Flow 516.45
    Particulars MAR 2023 (Values in Cr)
    Net Income 215.74
    Cash from Operations 280.83
    Cash from Investing -61.49
    Cash from Financing -135.79
    Net change in Cash 39.91
    Free Cash Flow 346.96
    Particulars MAR 2022 (Values in Cr)
    Net Income 82.16
    Cash from Operations 80.88
    Cash from Investing -95.51
    Cash from Financing 37.72
    Net change in Cash 2.59
    Free Cash Flow 178.56
    Particulars MAR 2026 (Values in Cr)
    Net Income 487.73
    Cash from Operations 450.97
    Cash from Investing -423.73
    Cash from Financing 20.97
    Net change in Cash -55.17
    Free Cash Flow 848.11
    Particulars MAR 2025 (Values in Cr)
    Net Income 345.37
    Cash from Operations 392.13
    Cash from Investing -298.13
    Cash from Financing 24.96
    Net change in Cash 44.33
    Free Cash Flow 598.57
    Particulars MAR 2024 (Values in Cr)
    Net Income 400.76
    Cash from Operations 371.62
    Cash from Investing -149.67
    Cash from Financing -69.28
    Net change in Cash 41.10
    Free Cash Flow 515.28
    Particulars MAR 2023 (Values in Cr)
    Net Income 215.21
    Cash from Operations 282.09
    Cash from Investing -61.49
    Cash from Financing -135.79
    Net change in Cash 41.23
    Free Cash Flow 348.22
    Particulars MAR 2022 (Values in Cr)
    Net Income 81.73
    Cash from Operations 80.93
    Cash from Investing -95.52
    Cash from Financing 37.72
    Net change in Cash 2.60
    Free Cash Flow 178.62
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.89 12.82 1.49 236.72 23.12 38.85
    BLISS GVS PHARMA LTD. 458.05 36.82 4.07 4857.91 118.35 552.90
    CIPLA LTD 1473.45 33.26 3.45 119031.97 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 451.45 21.12 3.26 1328.66 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.89 21.60 3.97 236.72 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 516.80 23.16 4.03 1494.10 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8179.35 106.89 23.42 20448.38 7630.00 9850.00
    BLISS GVS PHARMA LTD. 458.05 49.52 4.20 4857.91 118.35 552.90

    NEULAND LAB LTD. shareholding pattern

    Holding
    29.78%
    32.61%
    21.08%
    16.51%
    2.29%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    NEULAND LAB LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    19202.00 -2.51 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 19081.80
    • 26 Days 18591.60
    • 10 Days 18938.50
    • 50 Days 17906.80
    • 12 Days 18904.60
    • 100 Days 16821.50
    • 20 Days 18742.70
    • 200 Days 15804.80
    19464.67 PIVOT
    First Support 19114.33 First Resistance 20047.33 Second Support 18531.67 Second Resistance 20397.67 Third Support 18181.33 Third Resistance 20980.33
    RSI 66.02 ADX 23.91 MACD 313.02 Williams % R -6.70 Commodity Channel Index (CCI) 162.21
    Date 2026-07-29 Week 9655.00 Same Day 20606.00 Month 16353.00
    1 Year 0.89 3 Year 0.79
    Over 1 Month
    8.89% down
    Over 1 Year
    42.31% down
    Over 3 Months
    34.39% down
    Over 3 Years
    78.32% down
    Over 6 Months
    56.88% down
    Over 5 Years
    58.21% down

    NEULAND LAB LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    24 Jul 2026 34.0 Final 24 Jul 2026 Equity shares
    18 Jul 2025 12.0 Final 18 Jul 2025 Equity shares
    12 Jul 2024 14.0 Final 13 Jul 2024 Equity shares
    11 Jul 2023 10.0 Final 12 Jul 2023 Equity shares
    14 Jul 2022 5.0 Final 15 Jul 2022 Equity shares
    29 Jun 2021 3.0 Final 01 Jul 2021 Equity shares
    10 Nov 2020 2.0 Interim 11 Nov 2020 Equity shares
    18 Feb 2020 2.0 Interim 20 Feb 2020 Equity shares
    27 Jun 2019 1.2 Final 29 Jun 2019 Equity shares
    04 Aug 2016 2.0 Final 08 Aug 2016 Equity shares
    06 Aug 2015 1.5 Final 08 Aug 2015 Equity shares
    16 Jun 2014 1.5 Special 18 Jun 2014 Equity shares
    16 Jun 2014 1.5 Final 18 Jun 2014 Equity shares
    24 Jul 2013 1.2 Final 26 Jul 2013 Equity shares
    13 Jul 2009 3.5 Final 15 Jul 2009 Equity shares
    17 Jul 2008 2.5 Final 21 Jul 2008 Equity shares
    11 Jul 2007 2.5 Final 13 Jul 2007 Equity shares
    20 Jul 2005 0.0 Final 22 Jul 2005 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    24 Jul 2026 34.0 Final 24 Jul 2026 Equity shares
    18 Jul 2025 12.0 Final 18 Jul 2025 Equity shares
    12 Jul 2024 14.0 Final 13 Jul 2024 Equity shares
    11 Jul 2023 10.0 Final 12 Jul 2023 Equity shares
    14 Jul 2022 5.0 Final 15 Jul 2022 Equity shares
    29 Jun 2021 3.0 Final 01 Jul 2021 Equity shares
    10 Nov 2020 2.0 Interim 11 Nov 2020 Equity shares
    18 Feb 2020 2.0 Interim 20 Feb 2020 Equity shares
    27 Jun 2019 1.2 Final 29 Jun 2019 Equity shares
    04 Aug 2016 2.0 Final 08 Aug 2016 Equity shares
    06 Aug 2015 1.5 Final 08 Aug 2015 Equity shares
    16 Jun 2014 1.5 Special 18 Jun 2014 Equity shares
    16 Jun 2014 1.5 Final 18 Jun 2014 Equity shares
    24 Jul 2013 1.2 Final 26 Jul 2013 Equity shares
    13 Jul 2009 3.5 Final 15 Jul 2009 Equity shares
    17 Jul 2008 2.5 Final 21 Jul 2008 Equity shares
    11 Jul 2007 2.5 Final 13 Jul 2007 Equity shares
    20 Jul 2005 0.0 Final 22 Jul 2005 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Neuland Laboratories Ltd?

    Answer Field

    Neuland Laboratories Ltd share price is for NSE ₹ 19,200.00 & for BSE ₹ 19,250.00 as on Jul 30 2026 03:29 PM.

    What is the Market Cap of Neuland Laboratories Ltd Share?

    Answer Field

    The market cap of Neuland Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 30 2026 03:29 PM.

    What is the 52 Week High and Low of Neuland Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of Neuland Laboratories Ltd for NSE is ₹ 20,089.00 and ₹ 11,500.00 and for BSE is ₹ 20,072.00 and ₹ 11,500.00.

    What is 1 year return for Neuland Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been 42.31%.

    What is the P/E Ratio of Neuland Laboratories Ltd Share?

    Answer Field

    As on Jul 30 2026 03:29 PM the price-to-earnings (PE) ratio for Neuland Laboratories Ltd share is 69.67.

    What is the PB ratio of Neuland Laboratories Ltd Share?

    Answer Field

    As on Jul 30 2026 03:29 PM, the price-to-book (PB) ratio for Neuland Laboratories Ltd share is 1453.59.

    How to Buy Neuland Laboratories Ltd Share?

    Answer Field

    You can trade in Neuland Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Neuland Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Neuland Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Neuland Laboratories Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |